TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Infection transmission
Endpoint domain: Adverse events/effects
Primary endpoint: Number of organs donated
Endpoint domain: Resource use
Primary endpoint: LBP incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LTT measurements at T3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Elevation of IL‐1α, IL1ß, TNF‐α in group C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Elevation of CD4+ cells in group B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 5-year incidence of in-field relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulative early pregnancy loss rates
Endpoint domain: Adverse events/effects
Primary endpoint: Relief of symptom burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pro‐NT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in iron intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in vitamin C intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PACES scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean NRS at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean NRS during mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to SpO2 ≤95%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back pain-related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SOD (Superoxide Dismutase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TAC (Total Antioxidant Capacity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GPX (Glutathione Peroxidase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: composite of adjudicated venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or mortality within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Physical pain scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Uric acid excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Xanthine/hypoxanthine excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uric acid clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax,ss (peak plasma concentration at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCτ,ss (area under the plasma concentration‐time curve during the dosing interval at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total volume of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of moderate‐to‐vigorous‐intensity physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of light‐intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety composite of cardiovascular death and target vessel myocardial infarction
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with meaningful improvement in walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of cases marked as inactive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grades of peripheral caries in molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: passive ultimate stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of major bleeding (intracranial haemorrhage)
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening of disability at 12 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: delirium care knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of salivary SARS-CoV-2 load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SIS stage evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of myocardial infarction with hemodynamic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Deaths due to cardiac causes
Endpoint domain: Mortality/survival
Primary endpoint: percent change in FM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: carotid artery intima-media thickness (cIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: lower-limb pulse wave velocity (LL PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Insertion duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score (VNRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any grade acute GI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: bowel quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 1-month RAO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reaction times in executive function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of paroxysmal atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total success rate at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: worsening of distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VWF:Ag levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: VWF:GPIbM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: FVIII concentrate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adverse events (AEs) incidence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of misdiagnosis of GCTB as malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: number of different antiepileptic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: perceived effect on seizure control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin hydration (SCH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Risk of Heart Failure (HF) events
Endpoint domain: Mortality/survival
Primary endpoint: Risk of Major Adverse Cardiovascular Events (MACE)
Endpoint domain: Mortality/survival
Primary endpoint: diabetes-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: postwritten quiz scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total pass rate for the SSB exam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: communication and interaction pass rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite 1-year recurrence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of life score at 1 year
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain scores at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent infections
Endpoint domain: Adverse events/effects
Primary endpoint: Acquisition rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Exact agreement of reabstracted data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall completeness of data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mtb infection prevalence at 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: characteristic impedance (Zc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: forward wave pressures (Pf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Weaning off IMC duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percentage symptom reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in EPDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NMPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to reach or maintain sufficient weight
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Negative symptom subscale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General psychopathology subscale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NGS results obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to the first SBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PAC-SYM stool domain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PAC-QOL dissatisfaction domain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Response rate at any month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to onset of monthly response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low IQ score at age 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fasting serum insulin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skin hyperpigmentation and unevenness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vastus lateralis muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soleus muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived postural instability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Implicit negative bias toward MSM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean maximum plasma diazepam concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall diazepam exposure during the first four hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of informed consent documents
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: plasma levels of acylcarnitines, ceramides, and C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients showing complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS‐UPDRS‐3 ON score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fracture loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stress distribution patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: revision surgeries
Endpoint domain: Adverse events/effects
Primary endpoint: symmetry
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: plasma nicotine Cmax 0–120
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐120
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median Tmax 0–120
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h urinary sodium excretion (UNa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in α power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FU-EDSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: OHIP-14 score for functional limitation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: OHIP-14 score for physical pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: OHIP-14 score for psychological discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: New HIV diagnoses
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment response (≥50% reduction in GRID-HAMD score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk to develop active lesions on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: days of opioid use over the past 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of MOUD initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biological markers of health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worker health and safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decrease in depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: global QoR‐15 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean drainage period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of homolateral pneumothorax
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of total ESAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary Artery Compliance (CAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral Vascular Resistance (CVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Student satisfaction with jigsaw
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ischemic stroke incidence
Endpoint domain: Mortality/survival
Primary endpoint: Number of consultations attended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: gait endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-selected velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fast-paced velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: static strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction with mPCL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: App retention rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' overall satisfaction with the App
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increased adherence to therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete success in intraocular pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Serious complications during tube aperture
Endpoint domain: Adverse events/effects
Primary endpoint: procedural success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: access-site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in physical activity (PA) behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c reduction rate at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical efficacy of the IASD device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anatomic surgical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RV-to-left ventricular diameter ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PROMIS-PF-6b score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PEmb-QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fatigue-inertia score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: CR rates in the delayed phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily hot flush frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of PDPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FTMH closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient NOE (Negative Outcome Expectancy)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum D-lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum I-FABP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28-day prognosis prediction
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients achieving at least a very good partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative opioid consumption after 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean voiding symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintervention frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Cost difference between urethroplasty and urethrotomy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gastroesophageal reflux (GER) frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: decreased pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bleeding scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity motivation and participation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucagon stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Glycaemic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with appropriate dietary practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total operative time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self-care behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HF related in-hospital days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Guideline-compliant status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of buccal surfaces free of plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: birth satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HIV status knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow velocity of bilateral MCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Gut microbiota profile/composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of recruited patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: treatment outcome (symptoms and wellbeing)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Shoulder tip pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reoperation within 24 months
Endpoint domain: Adverse events/effects
Primary endpoint: Exclusive breastfeeding rates at postpartum day 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding rates until 6 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stature change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deep trunk muscle fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes